These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20647217)

  • 1. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Richart C; Auguet T; Terra X
    N Engl J Med; 2010 Jul; 363(2):193-4; author reply 195. PubMed ID: 20647217
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Salamone F; Galvano F; Li Volti G
    N Engl J Med; 2010 Jul; 363(2):194-5; author reply 195. PubMed ID: 20653078
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Valenti L; Nobili V; Fargion S
    N Engl J Med; 2010 Jul; 363(2):194; author reply 195. PubMed ID: 20653077
    [No Abstract]   [Full Text] [Related]  

  • 4. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
    Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
    Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to hepatic steatosis.
    Diehl AM
    N Engl J Med; 2010 Mar; 362(12):1142-3. PubMed ID: 20335592
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging genes associated with the progression of nonalcoholic fatty liver disease.
    Koutsari C; Lazaridis KN
    Hepatology; 2010 Sep; 52(3):807-10. PubMed ID: 20812353
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!
    Chalasani N
    Gastroenterology; 2009 Sep; 137(3):772-5. PubMed ID: 19638269
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Petersen KF; Dufour S; Hariri A; Nelson-Williams C; Foo JN; Zhang XM; Dziura J; Lifton RP; Shulman GI
    N Engl J Med; 2010 Mar; 362(12):1082-9. PubMed ID: 20335584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.
    Bekri S; Gual P; Anty R; Luciani N; Dahman M; Ramesh B; Iannelli A; Staccini-Myx A; Casanova D; Ben Amor I; Saint-Paul MC; Huet PM; Sadoul JL; Gugenheim J; Srai SK; Tran A; Le Marchand-Brustel Y
    Gastroenterology; 2006 Sep; 131(3):788-96. PubMed ID: 16952548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genetic variants in obesity-related nonalcoholic fatty liver disease.
    Mehta R; Birerdinc A; Younossi ZM
    Clin Liver Dis; 2014 Feb; 18(1):249-67. PubMed ID: 24274878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease.
    Oliveira CP; Stefano JT; Cavaleiro AM; Zanella Fortes MA; Vieira SM; Rodrigues Lima VM; Santos TE; Santos VN; de Azevedo Salgado AL; Parise ER; Ferreira Alves VA; Carrilho FJ; Corrêa-Giannella ML
    J Gastroenterol Hepatol; 2010 Feb; 25(2):357-61. PubMed ID: 19817962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans.
    Jun DW; Han JH; Jang EC; Kim SH; Kim SH; Jo YJ; Park YS; Chae JD
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):667-72. PubMed ID: 19262398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
    Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
    Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
    Akyildiz M; Gunsar F; Nart D; Sahin O; Yilmaz F; Akay S; Ersoz G; Karasu Z; Ilter T; Batur Y; Berdeli A; Akarca U
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):192-8. PubMed ID: 19829123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary conjugated linoleic acid induces tissue-specific lipoprotein lipase mRNA modulation in high-sucrose-fed mice.
    Castellanos-Tapia L; Yepiz-Plasencia G; Moya-Camarenaa SY
    Ann Nutr Metab; 2009; 54(2):131-7. PubMed ID: 19339774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease.
    Sookoian S; Castaño G; Gianotti TF; Gemma C; Rosselli MS; Pirola CJ
    Cytokine; 2008 Oct; 44(1):201-6. PubMed ID: 18789715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.